ATH 0.00% 4.8¢ alterity therapeutics limited

pbt2 progressing well

  1. 2,982 Posts.
    lightbulb Created with Sketch. 18
    I can't imagine this presentation would be happening if PBT2 is not progressing well.

    "Prana to Present at Rodman & Renshaw 9th Annual Healthcare Conference

    MELBOURNE, Australia – October 29, 2007: Prana Biotechnology Limited (NASDAQ: PRAN / ASX: PBT), a biopharmaceutical company focused on the research
    and development of treatments for neurodegenerative disorders, today announced that the Company is scheduled to present at the Rodman & Renshaw 9th Annual Global Healthcare Conference, on November 5-7, in New York City.

    Steve Targum, M.D., Chief Medical Advisor will give a presentation on November 7, at 3:00 p.m. EST on the Company’s lead product, PBT2, which is currently in a Phase IIa clinical trial for Alzheimer’s disease. The live presentation may be accessed at the Company’s website, or at
    A replay of the presentation will be archived for 90 days after the conference, at the same locations."
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Mkt cap ! $52.08M
Open High Low Value Volume
4.9¢ 4.9¢ 4.8¢ $24.27K 501.2K

Buyers (Bids)

No. Vol. Price($)
8 581877 4.8¢

Sellers (Offers)

Price($) Vol. No.
4.9¢ 282765 2
View Market Depth
Last trade - 16.10pm 28/09/2020 (20 minute delay) ?
0.000 ( 1.27 %)
Open High Low Volume
4.8¢ 4.9¢ 4.8¢ 382728
Last updated 15.59pm 28/09/2020 (live) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.